title: Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.
authors.affiliation: Department of Surgery, Ramathibodi Hospital Medical School, Mahidol University, Bangkok, Thailand.
authors.forename: S
authors.initials: S
authors.lastname: Jirasiritham
authors.forename: V
authors.initials: V
authors.lastname: Sumethkul
authors.forename: V
authors.initials: V
authors.lastname: Mavichak
authors.forename: S
authors.initials: S
authors.lastname: Jirasiritham
authors.forename: P
authors.initials: P
authors.lastname: Chiewsilp
authors.forename: C
authors.initials: C
authors.lastname: Leenanupunth
authors.forename: W
authors.initials: W
authors.lastname: Kochakarn
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D003404:Creatinine; D009173:Mycophenolic Acid; D001379:Azathioprine